Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schmieder

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Practice|February 11, 2012
Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registryU Zeymer, R Dechend, E Deeg, et al.
Nephron. Clinical Practice|April 6, 2005
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonateA J Hutchison, B Maes, J Vanwalleghem, et al.
Circulation|November 14, 2001
Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemiaC D Garlichs, S John, A Schmeisser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 13, 2010
Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCHChristian Ukena, F Mahfoud, M Kindermann, et al.
Journal of Human Hypertension|September 6, 2002
Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and designP Gosse, O Dubourg, P Guéret, et al.
Deutsche Medizinische Wochenschrift (1946)|February 6, 2014
[Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology]V Schwenger, B A Remppis, R Westenfeld, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 25, 2025
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosisJ Krefting, N Krüger, C Friess, et al.
Deutsche Medizinische Wochenschrift (1946)|November 4, 2011
[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]F Mahfoud, O Vonend, H Bruck, et al.
European Heart Journal Open|January 5, 2023
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patientsP Rossignol, K Duarte, E Bresso, et al.
Physical Review Letters|September 15, 2025
Measurement of WWZ and ZH Production Cross Sections at sqrt[s]=13 and 13.6 TeVA Hayrapetyan, V Makarenko, A Tumasyan, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Practice|February 11, 2012
Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registryU Zeymer, R Dechend, E Deeg, et al.
Nephron. Clinical Practice|April 6, 2005
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonateA J Hutchison, B Maes, J Vanwalleghem, et al.
Circulation|November 14, 2001
Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemiaC D Garlichs, S John, A Schmeisser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 13, 2010
Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCHChristian Ukena, F Mahfoud, M Kindermann, et al.
Journal of Human Hypertension|September 6, 2002
Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and designP Gosse, O Dubourg, P Guéret, et al.
Deutsche Medizinische Wochenschrift (1946)|February 6, 2014
[Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology]V Schwenger, B A Remppis, R Westenfeld, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 25, 2025
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosisJ Krefting, N Krüger, C Friess, et al.
Deutsche Medizinische Wochenschrift (1946)|November 4, 2011
[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]F Mahfoud, O Vonend, H Bruck, et al.
European Heart Journal Open|January 5, 2023
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patientsP Rossignol, K Duarte, E Bresso, et al.
Physical Review Letters|September 15, 2025
Measurement of WWZ and ZH Production Cross Sections at sqrt[s]=13 and 13.6 TeVA Hayrapetyan, V Makarenko, A Tumasyan, et al.
Pageof 4